TRIANA BIOMEDICINES

What this means for you

Not registered yet, but its 22 Feb 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

97278196

Mark type

Stylized text

Filed

22 Feb 2022

Published for opposition

18 Jul 2023

Attorney of record

Susan Neuberger Weller

Goods and services

• Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of conditions and diseases in the fields of cancer and immunology
• Class 042 — Scientific and technological services: research and development in the field of small molecule medicines for the treatment of conditions and diseases in the fields of cancer, neurology, immunology, cardiovascular disease, monogenic diseases, and metabolic diseases; scientific research in the nature of conducting medical and scientific research, namely, conducting clinical trials for others in the field of small molecule medicines for the treatment of conditions and diseases in the fields of cancer, neurology, immunology, cardiovascular disease, monogenic diseases, and metabolic diseases

Owner

• Triana Biomedicines, Inc., Lexington, MA, US
• Triana Biomedicines, Inc., Waltham, MA, US

Prosecution history

• 10 Sept 2026 — STATEMENT OF USE PROCESSING COMPLETE
• 08 Sept 2026 — USE AMENDMENT FILED
• 08 Sept 2026 — TEAS STATEMENT OF USE RECEIVED
• 12 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 12 May 2026 — SOU EXTENSION 5 GRANTED
• 11 Dec 2025 — SOU EXTENSION 5 FILED
• 12 May 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 12 Dec 2025 — SOU TEAS EXTENSION RECEIVED
• 26 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 25 Mar 2025 — SOU EXTENSION 4 GRANTED
• 25 Mar 2025 — SOU EXTENSION 4 FILED
• 25 Mar 2025 — SOU TEAS EXTENSION RECEIVED
• 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 16 Dec 2024 — SOU EXTENSION 3 GRANTED
• 16 Dec 2024 — SOU EXTENSION 3 FILED